USPTO serial 79448587
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of mucopolysaccharidosis; pharmaceutical preparations for the treatment of Fabry disease; pharmaceutical preparations for the treatment of renal anemia; pharmaceutical preparations for the treatment of growth hormone deficiency in adults and children; pharmaceutical preparations for the treatment of graft-versus-host disease; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of rare diseases; biological preparations for use in cell cultures for medical purposes; biological preparations for gene therapy for the treatment of genetic diseases or disorders; enzymes for medical purposes; proteins for medical purposes; hormones for medical purposes; cells for medical use; blood for medical purposes; vaccines; biological tissue cultures for medical purposes; bacteriological preparations for medical purposes; preparations of microorganisms for medical purposes; dietary supplements for human beings; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 2, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 2, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 24, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 23, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 4, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 4, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 4, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 23, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |